113 related articles for article (PubMed ID: 9433040)
1. Emergence of an irreversible differentiated subclone from the poorly differentiated ovarian adenocarcinoma cell line AMOC-2 treated with sodium butyrate.
Yabushita H; Noguchi M; Nakanishi M
J Obstet Gynaecol Res; 1997 Dec; 23(6):493-502. PubMed ID: 9433040
[TBL] [Abstract][Full Text] [Related]
2. Effects of sodium butyrate, dimethylsulfoxide and dibutyryl cAMP on the poorly differentiated ovarian adenocarcinoma cell line AMOC-2.
Yabushita H; Sartorelli AC
Oncol Res; 1993; 5(4-5):173-82. PubMed ID: 8305743
[TBL] [Abstract][Full Text] [Related]
3. Emergence of differentiated subclones from a human salivary adenocarcinoma cell clone in culture after treatment with sodium butyrate.
Azuma M; Hayashi Y; Yoshida H; Yanagawa T; Yura Y; Ueno A; Sato M
Cancer Res; 1986 Feb; 46(2):770-7. PubMed ID: 3000585
[TBL] [Abstract][Full Text] [Related]
4. Effect of sodium butyrate and other differentiation inducers on poorly differentiated human ovarian adenocarcinoma cell lines.
Langdon SP; Hawkes MM; Hay FG; Lawrie SS; Schol DJ; Hilgers J; Leonard RC; Smyth JF
Cancer Res; 1988 Nov; 48(21):6161-5. PubMed ID: 3167862
[TBL] [Abstract][Full Text] [Related]
5. Ultrastructural differentiation of sodium butyrate-treated human pancreatic adenocarcinoma cell lines.
Mullins TD; Kern HF; Metzgar RS
Pancreas; 1991 Sep; 6(5):578-87. PubMed ID: 1946315
[TBL] [Abstract][Full Text] [Related]
6. Stable differentiation of a human colon adenocarcinoma cell line by sodium butyrate is associated with multidrug resistance.
Ho SB; Yan PS; Dahiya R; Neuschwander-Tetri BA; Basbaum C; Kim YS
J Cell Physiol; 1994 Aug; 160(2):213-26. PubMed ID: 7913708
[TBL] [Abstract][Full Text] [Related]
7. Effects of sodium butyrate on the secretion of beta-2-microglobulin and calcitonin in a human ovarian cancer cell line OC-3-VGH.
Chang CC; Chao KC; Ng HT
Zhonghua Yi Xue Za Zhi (Taipei); 1988 Aug; 42(2):93-8. PubMed ID: 3066455
[No Abstract] [Full Text] [Related]
8. Establishment and characterization of two human ovarian clear cell adenocarcinoma lines from metastatic lesions with different properties.
Gorai I; Nakazawa T; Miyagi E; Hirahara F; Nagashima Y; Minaguchi H
Gynecol Oncol; 1995 Apr; 57(1):33-46. PubMed ID: 7535723
[TBL] [Abstract][Full Text] [Related]
9. Effect of differentiation agents on expression of CA 125, alkaline phosphatase, and cytokeratins in human ovarian adenocarcinoma cells (OVCA 433).
Brooks SE; Timmerman J; Lau CC; Tsao SW; Knapp RC; Sheets EE
Gynecol Oncol; 1991 Sep; 42(3):265-72. PubMed ID: 1720110
[TBL] [Abstract][Full Text] [Related]
10. Establishment and characterization of six new human endometrial adenocarcinoma cell lines.
Möbus V; Gerharz CD; Mitze M; Moll R; Pollow K; Kother T; Knapstein PG; Kreienberg R
Gynecol Oncol; 1993 Mar; 48(3):370-83. PubMed ID: 7681807
[TBL] [Abstract][Full Text] [Related]
11. [Reorganization of human ovarian adenocarcinoma cells and endometrial adenocarcinoma cells cultured in double-layered floating collagen gels].
Tsumura N; Kudo R; Sawada N
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Dec; 38(12):2157-70. PubMed ID: 3027213
[TBL] [Abstract][Full Text] [Related]
12. Establishment and characterization of a new human cell-line (AMOC-2) derived from a serous adenocarcinoma of ovary.
Yabushita H; Ueno N; Sawaguchi K; Higuchi K; Noguchi M; Ishihara M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jul; 41(7):888-94. PubMed ID: 2794621
[TBL] [Abstract][Full Text] [Related]
13. Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate.
Augeron C; Laboisse CL
Cancer Res; 1984 Sep; 44(9):3961-9. PubMed ID: 6744312
[TBL] [Abstract][Full Text] [Related]
14. Ultrastructural differentiation and CEA expression of butyrate-treated human pancreatic carcinoma cells.
el-Deriny SE; O'Brien MJ; Christensen TG; Kupchik HZ
Pancreas; 1987; 2(1):25-33. PubMed ID: 3575313
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of BCS-TC2 human colon adenocarcinoma cells by sodium butyrate: increase in 5'-nucleotidase activity.
Navarro JM; Olmo N; Turnay J; López-Conejo MT; Lizarbe MA
Eur J Clin Invest; 1997 Jul; 27(7):620-8. PubMed ID: 9263751
[TBL] [Abstract][Full Text] [Related]
16. Morphologic characteristics, proliferation, and tumor marker expression of two human ovarian carcinoma cell lines in three-dimensional culture.
Morimitsu Y; Yano H; Kojiro M
Gynecol Oncol; 1993 Feb; 48(2):155-64. PubMed ID: 8428685
[TBL] [Abstract][Full Text] [Related]
17. Progression of hormone-dependent adenocarcinoma cells to hormone-independent spindle carcinoma cells in vitro in a clonal spontaneous rat mammary tumor cell line.
Nakanishi H; Taylor RM; Chrest FJ; Masui T; Utsumi K; Tatematsu M; Passaniti A
Cancer Res; 1995 Jan; 55(2):399-407. PubMed ID: 7529136
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of pancreatic carcinoma induced by retinoic acid or sodium butyrate: a morphological and molecular analysis of four cell lines.
Egawa N; Maillet B; VanDamme B; De Grève J; Klöppel G
Virchows Arch; 1996 Sep; 429(1):59-68. PubMed ID: 8865855
[TBL] [Abstract][Full Text] [Related]
19. The effect of sodium butyrate and retinoic acid on growth and CEA production in a series of human colorectal tumor cell lines representing different states of differentiation.
Niles RM; Wilhelm SA; Thomas P; Zamcheck N
Cancer Invest; 1988; 6(1):39-45. PubMed ID: 3365571
[TBL] [Abstract][Full Text] [Related]
20. Antibody-mediated targeting of differentiation inducers to tumor cells: inhibition of colonic cancer cell growth in vitro and in vivo. A preliminary note.
Otaka M; Singhal A; Hakomori S
Biochem Biophys Res Commun; 1989 Jan; 158(1):202-8. PubMed ID: 2912449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
